Lovick Edward Cannon
Amministratore Delegato presso Unigen Pharmaceuticals, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Todd C. Zion | M | - |
SmartCells, Inc.
 SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA.
Akston Biosciences Corp.
 Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | 13 anni |
| Thomas M. Lancaster | M | - |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | 13 anni |
| Sathi Sathiyaseelan | M | - |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | - |
| John Preston | M | 74 |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | 1 anni |
| Gregory S. Dane | M | - |
NovAb, Inc.
 NovAb, Inc. NovAb, Inc. provides healthcare services. The company was incorporated in 2013 and is headquartered in Tucker, GA. | - |
| Robyn Davis | F | 63 |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | 10 anni |
| James M. Herriman | M | - |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ansbert Gadicke | M | 66 |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | - |
| Vaughn M. Kailian | M | 79 |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | 6 anni |
| Ben Shapiro | M | 84 |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | - |
| Peter S. DiStefano | M | 66 |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | - |
| Vernon Cassin | M | 71 |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | - |
| Alan Watson | M | 65 |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | - |
| Bard J. Geesaman | M | 56 |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | 4 anni |
| Robert J. Manning | M | - |
SmartCells, Inc.
SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 15 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Lovick Edward Cannon
- Contatti personali
